Reduction in integrin a3b1 modulates lung cancer motility and invasion through p70S6K-dependent E-cadherin

Young-Rak Cho1, Eun-Kyung Ahn2, Yoon Gyoon Kim3

  • 1Department of Pharmacy, College of Pharmacy, Dankook University, Cheonan 31116, Republic of Korea. yrcho@gbsa.or.kr.

Insights

Integrin alpha3beta1 (α3β1) targeting inhibits non-small cell lung cancer (NSCLC) migration and invasion by affecting E-cadherin and p70S6K signaling, particularly in p53 wild-type cells. This suggests a new therapeutic strategy for NSCLC treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Integrin alpha3beta1 (α3β1) plays a role in cell adhesion and signaling.
  • Non-small cell lung cancer (NSCLC) progression involves complex molecular mechanisms.
  • The interplay between integrins, cell adhesion molecules, and signaling pathways in NSCLC is not fully understood.

Purpose of the Study:

  • To investigate the role of integrin α3β1 in non-small cell lung cancer (NSCLC) growth and progression.
  • To elucidate the underlying mechanism of integrin α3β1 action in NSCLC cells.
  • To explore the potential of the integrin α3β1-p70S6K-p53 network as a therapeutic target for NSCLC.

Main Methods:

  • RNA silencing was used to reduce integrin α3 expression in A549 NSCLC cells (p53 wild-type).
  • Cell migration and invasion assays were performed.
  • Epithelial cadherin (E-cadherin) distribution and p70 S6 kinase (p70S6K) activation were assessed.
  • The effects of E-cadherin disruption and p70S6K blockade were evaluated.

Main Results:

  • Reduced integrin α3 expression inhibited cell migration and invasion in p53 wild-type NSCLC cells.
  • These anti-migratory and anti-invasive effects were linked to E-cadherin distribution and required p70S6K activation.
  • Disruption of E-cadherin or p70S6K blockade abolished the inhibitory effects of integrin α3 silencing on migration and invasion.
  • Enhanced proliferation in integrin α3-silenced cells was not affected by E-cadherin expression changes.

Conclusions:

  • Integrin α3β1 differentially regulates NSCLC cell growth and progression based on p53 status.
  • The integrin α3β1-p70S6K-p53 signaling network is a potential therapeutic target for NSCLC.
  • Targeting integrin α3β1 may offer a novel strategy for treating NSCLC, particularly in tumors with wild-type p53.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.6K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.3K
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
3.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
2.9K
Microtubules in Cell Motility01:24

Microtubules in Cell Motility

Microtubules are thick hollow cylindrical proteins that help form the cytoskeleton. Microtubules have varied roles in the cell. These filaments help form cellular appendages like cilia and flagella, which are responsible for locomotion. The cilia arise from basal bodies, separated from the main body by a membrane-like structure forming the transition zone. This zone is the gate for the entry of lipids and proteins, creating a unique composition of lipids and proteins in the ciliary membrane and...
3.2K